Clinical and Experimental Pediatrics

The Korean Pediatric Society (대한소아청소년과학회)
권호 표지
DOI QR코드

DOI QR Code

Factors for persistent growth hormone deficiency in young adults with childhood onset growth hormone deficiency

소아청소년기 성장호르몬결핍증의 성인기 지속에 영향을 미치는 요인

  • Lee, Young Ah (Department of Pediatrics, College of Medicine, Seoul National University) ;
  • Chung, Hye Rim (Department of Pediatrics, College of Medicine, Seoul National University) ;
  • Lee, Se Min (Department of Pediatrics, College of Medicine, Hanyang University) ;
  • Kim, Jae Hyun (Department of Pediatrics, College of Medicine, Seoul National University) ;
  • Kim, Ji Hyun (Department of Pediatrics, College of Medicine, Seoul National University) ;
  • Lee, Sun Hee (Department of Pediatrics, College of Medicine, Seoul National University) ;
  • Shin, Choong Ho (Department of Pediatrics, College of Medicine, Seoul National University) ;
  • Yang, Sei Won (Department of Pediatrics, College of Medicine, Seoul National University)
  • 이영아 (서울대학교 의과대학 소아과학교실) ;
  • 정혜림 (서울대학교 의과대학 소아과학교실) ;
  • 이세민 (한양대학교 의과대학 소아과학교실) ;
  • 김재현 (서울대학교 의과대학 소아과학교실) ;
  • 김지현 (서울대학교 의과대학 소아과학교실) ;
  • 이선희 (서울대학교 의과대학 소아과학교실) ;
  • 신충호 (서울대학교 의과대학 소아과학교실) ;
  • 양세원 (서울대학교 의과대학 소아과학교실)
  • Received : 2008.01.13
  • Accepted : 2008.01.27
  • Published : 2009.02.15
Download PDF
⟨ Previous Next ⟩

Abstract

Purpose : Growth hormone (GH) replacement after retesting is necessary because impairment of body composition and cardiovascular health has been more severe in adult patients with persistent GH deficiency (GHD) from childhood to adulthood. This study aimed to investigate the factors for persistent GHD and define a highly probable group of persistent GHD in young adults with childhood-onset GHD. Methods : GHD was reassessed by insulin tolerance test (ITT) in 55 adult patients (39 males, 16 females) with childhood-onset GHD. Twelve patients presented with idiopathic GHD and 43 patients presented with organic GHD caused by tumors involving the hypothalamus-pituitary (H-P) region (n=33), other brain tumors (n=3), meningitis (n=3), leukemia (n=2) and others (n=2). Results : Forty-nine (89.1%) of 55 patients had persistent GHD. IGF-I was positively correlated with log of peak GH (r=0.57, P<0.001). There was no difference in the proportion of persistent GHD between idiopathic and organic GHD. The percentage of patients with persistent GHD was 40%, 80%, and 95.6% for patients with zero, one, two or more additional pituitary hormone deficiencies (PHDs), respectively (P=0.002). The probability of persistent GHD was higher in patients with diseases involving the H-P region (P=0.003). GHD persisted in 15 of 18 patients treated with cranial irradiation. Conclusion : We suggest that the probability of persistent GHD in adulthood was high in patients with 2 or more additional PHDs, and diseases involving the H-P region.

목 적 : 소아청소년기 GHD 환자들은 성인기에 진단된 환자보다 체성분과 심혈관계의 변화가 심한 것으로 알려져 있어 성인기에도 GHD가 지속되면 성장호르몬 치료를 꼭 받아야 한다. 본 연구에서는 소아청소년기에 GHD로 진단 받은 성인 환자들을 대상으로 ITT를 시행하여 성인기에도 GHD가 지속되는 요인을 살펴보고, 성인기에도 GHD가 지속될 가능성이 높은 대상을 알아보고자 한다. 방 법 : 성인키에 도달한 55명(남 39명, 여 16명)을 대상으로 ITT의 최대 성장호르몬 값이 $3{\mu}g/L$ 미만이면 성인기 GHD로 진단하였다. 특발성 GHD 환자(n=12)는 뇌하수체 구조적인 이상이 있는 2명과 둔위 분만 또는 가사의 병력이 있는 10명이었으며, 기질성 GHD 환자(n=43)는 시상하부-뇌하수체를 침범하는 뇌종양(n=33), 그 외의 뇌종양(n=3), 뇌수막염(n=3), 백혈병(n= 2), 지주막낭종(n=1), 뇌하수체염(n=1)에 해당하였다. 결 과 : 성인기에도 GHD가 지속된 환자는 49명(89.1%)이었다. 최대 성장호르몬 값의 log값은 기저 IGF-I 농도와 양의 상관관계를 보였다(r=0.57, P<0.001). 특발성 GHD 환자의 91.7%가 성인기에도 GHD가 지속되어, 성인기 GHD 여부는 소아청소년기 특발성, 기질성 GHD 여부에 따른 차이가 없었다. 동반된 뇌하수체호르몬 결핍 개수가 많을수록(단독 GHD 40%, 1개의 결핍 동반 80%, 2개 이상 동반 95.6%, P=0.002), 기질성 GHD 환자 중에서 병변이 시상하부-뇌하수체를 일차적으로 침범하는 경우(P=0.003)에 성인기에도 GHD가 지속될 가능성이 높았다. 두개 내 방사선 치료를 받은 18명 중에서 15명이 성인기에도 GHD가 지속되었는데, 시상하부-뇌하수체를 침범하는 종양으로 방사선 치료를 받은 환자들 14명은 모두 방사선조사량에 관계없이 성인기에도 GHD가 지속되었다. 동반된 뇌하수체호르몬 결핍이 있는 경우(P=0.005), 소아청소년기 완전 GHD인 경우(P=0.005)에 성인기에도 GHD가 지속되는 비율이 높았다. 결 론 : 소아청소년기에 GHD로 진단 받은 환자들 중에서 동반 뇌하수체호르몬 결핍이 2개 이상이거나, 기저 질환의 병변이 시상하부-뇌하수체를 포함하면 성인기에도 GHD가 지속될 가능성이 높다.

Keywords

References

  1. Attanasio AF, Shalet SM. Growth hormone and the transition from puberty into adulthood. Endocrinol Metab Clin North Am 2007;36:187-201 https://doi.org/10.1016/j.ecl.2006.11.002
  2. Johannsson G, Albertsson-Wikland K, Bengtsson BA. Discontinuation of growth hormone (GH) treatment: metabolic effects in GH-deficient and GH-sufficient adolescent patients compared with control subjects. Swedish Study Group for Growth Hormone Treatment in Children. J Clin Endocrinol Metab 1999:84:4516-24 https://doi.org/10.1210/jc.84.12.4516
  3. Hoffman DM, O'Sullivan AJ, Freund J, Ho KK. Adults with growth hormone deficiency have abnormal body composition but normal energy metabolism. J Clin Endocrinol Metab 1995;80:72-7 https://doi.org/10.1210/jc.80.1.72
  4. Molitch ME, Clemmons DR, Malozowski S, Merriam GR, Shalet SM, Vance ML, et al. Evaluation and treatment of adult growth hormone deficiency: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab 2006;91: 1621-34 https://doi.org/10.1210/jc.2005-2227
  5. Attanasio AF, Lamberts SW, Matranga AM, Birkett MA, Bates PC, Valk NK, et al. Adult growth hormone (GH)-deficient patients demonstrate heterogeneity between childhood onset and adult onset before and during human GH treatment. Adult Growth Hormone Deficiency Study Group. J Clin Endocrinol Metab 1997;82:82-8 https://doi.org/10.1210/jc.82.1.82
  6. Nilsson AG, Svensson J, Johannsson G. Management of growth hormone deficiency in adults. Growth Horm IGF Res 2007;17:441-62 https://doi.org/10.1016/j.ghir.2007.05.005
  7. Radovick S, DiVall S. Approach to the growth hormone- deficient child during transition to adulthood. J Clin Endocrinol Metab 2007;92:1195-200 https://doi.org/10.1210/jc.2007-0167
  8. Clayton PE, Cuneo RC, Juul A, Monson JP, Shalet SM, Tauber M. Consensus statement on the management of the GH-treated adolescent in the transition to adult care. Eur J Endocrinol 2005;152:165-70 https://doi.org/10.1530/eje.1.01829
  9. Ghigo E, Aimaretti G, Corneli G. Diagnosis of adult GH deficiency. Growth Horm IGF Res 2008;18:1-16 https://doi.org/10.1016/j.ghir.2007.07.004
  10. Consensus guidelines for the diagnosis and treatment of adults with growth hormone deficiency: summary statement of the Growth Hormone Research Society Workshop on Adult Growth Hormone Deficiency. J Clin Endocrinol Metab 1998;83:379-81 https://doi.org/10.1210/jc.83.2.379
  11. Guo SS, Chumlea WC, Roche AF, Siervogel RM. Age- and maturity-related changes in body composition during adolescence into adulthood: the Fels Longitudinal Study. Int J Obes Relat Metab Disord 1997;21:1167-75 https://doi.org/10.1038/sj.ijo.0800531
  12. Attanasio AF, Howell S, Bates PC, Blum WF, Frewer P, Quigley C, et al. Confirmation of severe GH deficiency after final height in patients diagnosed as GH deficient during childhood. Clin Endocrinol (Oxf) 2002;56:503-7 https://doi.org/10.1046/j.1365-2265.2002.01515.x
  13. Maghnie M, Strigazzi C, Tinelli C, Autelli M, Cisternino M, Loche S, et al. Growth hormone (GH) deficiency (GHD) of childhood onset: reassessment of GH status and evaluation of the predictive criteria for permanent GHD in young adults. J Clin Endocrinol Metab 1999;84:1324-8 https://doi.org/10.1210/jc.84.4.1324
  14. Wacharasindhu S, Cotterill AM, Camacho-Hubner C, Besser GM, Savage MO. Normal growth hormone secretion in growth hormone insufficient children retested after completion of linear growth. Clin Endocrinol (Oxf) 1996;45:553-6 https://doi.org/10.1046/j.1365-2265.1996.00850.x
  15. Tauber M, Moulin P, Pienkowski C, Jouret B, Rochiccioli P. Growth hormone (GH) retesting and auxological data in 131 GH-deficient patients after completion of treatment. J Clin Endocrinol Metab 1997;82:352-6 https://doi.org/10.1210/jc.82.2.352
  16. Clayton PE, Price DA, Shalet SM. Growth hormone state after completion of treatment with growth hormone. Arch Dis Child 1987;62:222-6 https://doi.org/10.1136/adc.62.3.222
  17. Cacciari E, Tassoni P, Parisi G, Pirazzoli P, Zucchini S, Mandini M, et al. Pitfalls in diagnosing impaired growth hormone (GH) secretion: retesting after replacement therapy of 63 patients defined as GH deficient. J Clin Endocrinol Metab 1992;74:1284-9 https://doi.org/10.1210/jc.74.6.1284
  18. Maghnie M, Moretta A, Valtorta A, Larizza D, Sayegh M, Greco AM, et al. Growth hormone response to growth hormone-releasing hormone varies with the hypothalamic-pituitary abnormalities. Eur J Endocrinol 1996;135:198-204 https://doi.org/10.1530/eje.0.1350198
  19. DH Kim, EG Yoo. Reassessment of growth hormone status and metabolic disturbance in young adults with childhood- onset GH deficiency. Korean J Pediatr 2002;7:190-8
  20. Juul A, Kastrup KW, Pedersen SA, Skakkebaek NE. Growth hormone (GH) provocative retesting of 108 young adults with childhood-onset GH deficiency and the diagnostic value of insulin-like growth factor I (IGF-I) and IGF-binding protein-3. J Clin Endocrinol Metab 1997;82:1195-201 https://doi.org/10.1210/jc.82.4.1195
  21. Hartman ML, Crowe BJ, Biller BM, Ho KK, Clemmons DR, Chipman JJ. Which patients do not require a GH stimulation test for the diagnosis of adult GH deficiency? J Clin Endocrinol Metab 2002;87:477-85 https://doi.org/10.1210/jc.87.2.477
  22. Clayton PE, Shalet SM. Dose dependency of time of onset of radiation-induced growth hormone deficiency. J Pediatr 1991;118:226-8 https://doi.org/10.1016/S0022-3476(05)80487-1
  23. Brennan BM, Rahim A, Mackie EM, Eden OB, Shalet SM. Growth hormone status in adults treated for acute lymphoblastic leukaemia in childhood. Clin Endocrinol (Oxf) 1998; 48:777-83 https://doi.org/10.1046/j.1365-2265.1998.00438.x
  24. Nandagopal R, Laverdiere C, Mulrooney D, Hudson MM, Meacham L. Endocrine late effects of childhood cancer therapy: a report from the Children's Oncology Group. Horm Res 2008;69:65-74 https://doi.org/10.1159/000111809
  25. Hoeck HC, Jakobsen PE, Vestergaard P, Falhof J, Laurberg P. Differences in reproducibility and peak growth hormone responses to repeated testing with various stimulators in healthy adults. Growth Horm IGF Res 1999;9:18-24 https://doi.org/10.1054/ghir.1998.0085
  26. Vestergaard P, Hoeck HC, Jakobsen PE, Laurberg P. Reproducibility of growth hormone and cortisol responses to the insulin tolerance test and the short ACTH test in normal adults. Horm Metab Res 1997;29:106-10 https://doi.org/10.1055/s-2007-979000
  27. Aimaretti G, Baffoni C, DiVito L, Bellone S, Grottoli S, Maccario M, et al. Comparisons among old and new provocative tests of GH secretion in 178 normal adults. Eur J Endocrinol 2000;142:347-52 https://doi.org/10.1530/eje.0.1420347
  28. Maccario M, Grottoli S, Procopio M, Oleandri SE, Rossetto R, Gauna C, et al. The GH/IGF-I axis in obesity: influence of neuro-endocrine and metabolic factors. Int J Obes Relat Metab Disord 2000 ;24 Suppl 2:S96-9
  29. Biller BM, Samuels MH, Zagar A, Cook DM, Arafah BM, Bonert V, et al. Sensitivity and specificity of six tests for the diagnosis of adult GH deficiency. J Clin Endocrinol Metab 2002;87:2067-79 https://doi.org/10.1210/jc.87.5.2067
  30. Jorgensen JO, Vahl N, Hansen TB, Skjaerbaek C, Fisker S, Orskov H, et al. Determinants of serum insulin-like growth factor I in growth hormone deficient adults as compared to healthy subjects. Clin Endocrinol (Oxf) 1998;48:479-86 https://doi.org/10.1046/j.1365-2265.1998.00424.x